The cluster of C-suite selling, while small in proportion to market cap, is a modest negative signal ahead of the upcoming FDA decision on relacorilant. Monitor for any additional insider sales or negative pre-announcements. The stock's strong recent run (+15% T+20 on prior neutral calls) suggests momentum may persist, but this insider activity adds a note of caution.
Price Chart
Executive Summary
Three Corcept insiders, including the Chief Business Officer and Chief Development Officer, sold a total of $1.82M in open-market sales over a week. The CBO's $1.16M sale is the largest single transaction. While the dollar amount is modest relative to CORT's $12.7B market cap (~0.014%), the cluster of C-suite selling warrants attention, especially given the stock's strong recent performance and the company's upcoming catalyst (FDA decision on relacorilant). The historical calibration suggests cluster sells are not strongly predictive, but the concentration in senior management is notable.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $1.82M in open-market sales over a week.
- Chief Business Officer Robb Gary Charles sold $1.16M on August 17.
- Chief Development Officer Guyer William sold $544K on August 10.
- Total sales represent ~0.014% of CORT's $12.7B market cap.
- The cluster includes C-suite executives, which carries more weight than director-level sales.
Financial Impact
Insider sales of $1.82M, representing 0.014% of market cap
Risk Factors
- Insider sales may signal management's view that the stock is fully valued ahead of a binary catalyst.
- The FDA decision on relacorilant (expected Q4 2026) is a high-stakes event that could drive significant volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1787119850986 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $115.63 | ▲ +1.54% | ▲ +1.28% | $116.49 (+2.29%) |
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $116.10 | ▲ +1.95% | ▲ +1.44% | $116.49 (+2.29%) |
Aug 27, 2026 5w ago | Insider Cluster | $116.93 $117.00 | ▲ +0.06% | ▲ +0.16% | $116.49 (−0.38%) |
Aug 20, 2026 6w ago | Insider Cluster | $121.05 $114.86 | ▼ −5.11% | ▼ −5.11% | $116.49 (−3.77%) |
Aug 18, 2026 6w ago | Insider Cluster | $118.10 $111.85 | ▲ +5.29% | ▲ +4.30% | $116.49 (+1.36%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 6, 2026 8w ago | Insider Cluster | $110.77 $111.62 | ▲ +0.77% | ▲ +1.16% | $116.49 (+5.16%) |
Aug 5, 2026 8w ago | Insider Cluster | $107.95 $112.80 | ▲ +4.49% | ▲ +3.89% | $116.49 (+7.91%) |
Jul 23, 2026 10w ago | Court Ruling | $96.66 $121.05 | ▲ +25.23% | ▲ +21.92% | $116.49 (+20.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access